4.97 USD
0 (0%)
4.99 USD
+0.02 (+0.4%)
ChartMill assigns a Buy % Consensus number of 76% to BLUE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.84. This target is 77.87% above the current price.
BLUE was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BLUE.
In the previous month the buy percentage consensus was at a similar level.
BLUE was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-24 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-12-31 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-15 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-15 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-15 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-09-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-08-15 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-15 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-15 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-15 | B of A Securities | Maintains | Buy -> Buy |
| 2024-03-27 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-03-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-19 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-03-05 | HSBC | Maintains | Reduce -> Reduce |
| 2023-12-21 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-12 | Baird | Maintains | Outperform -> Outperform |
| 2023-12-11 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-08 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-11-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-10-17 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-09-06 | HSBC | Initiate | Buy |
| 2023-07-19 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-07-11 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-06-01 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2023-04-28 | JP Morgan | Initiate | Overweight |
BLUEBIRD BIO INC / BLUE FAQ
What is the price target for BLUE stock?
10 analysts have analysed BLUE and the average price target is 8.84 USD. This implies a price increase of 77.87% is expected in the next year compared to the current price of 4.97.
What is the consensus rating for BLUE stock?
The consensus rating for BLUEBIRD BIO INC (BLUE) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.